000 01310 a2200289 4500
005 20250514035151.0
264 0 _c20020718
008 200207s 0 0 eng d
022 _a1175-2203
024 7 _a10.2165/00129785-200202010-00003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHagan, Christy R
245 0 0 _aMobile genetic element activation and genotoxic cancer therapy: potential clinical implications.
_h[electronic resource]
260 _bAmerican journal of pharmacogenomics : genomics-related research in drug development and clinical practice
_c2002
300 _a25-35 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aDNA Methylation
650 0 4 _aDNA Transposable Elements
650 0 4 _aHumans
650 0 4 _aMutagens
_xadverse effects
650 0 4 _aShort Interspersed Nucleotide Elements
650 0 4 _aTranscription, Genetic
700 1 _aRudin, Charles M
773 0 _tAmerican journal of pharmacogenomics : genomics-related research in drug development and clinical practice
_gvol. 2
_gno. 1
_gp. 25-35
856 4 0 _uhttps://doi.org/10.2165/00129785-200202010-00003
_zAvailable from publisher's website
999 _c11978541
_d11978541